How Fitusiran Changes the Treatment Landscape in Hemophilia: Guy Young, MD
Ongoing Research in Plasminogen Deficiency Type 1: Dr Amy Shapiro
Patients With Plasminogen Deficiency Should Receive Care at Hemophilia Treatment Centers: Dr Amy Shapiro
Ryplazim Marks First FDA Approval for Plasminogen Deficiency: Dr Amy Shapiro
Ligneous Lesions Often Misdiagnosed in Rare Plasminogen Deficiency: Dr Amy Shapiro
Dr Kevin Davies Discusses Challenges of Streamlining CRISPR Technology Delivery
Dr David Eagle: Progress in Hematology/Oncology Is Not Without Its Difficulties
Pegcetacoplan May Reduce Fatigue in PNH Accompanied by Anemia